Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Sure are! I wonder why nobody is buying this "gem"??
Quote:
Plenty of shares on the ask below .066.
Buyers Beware.
If ind is coming then pmcb is the first biotech in history that didn't have buyers coming in and running the price up. Actions speak louder than the bullshit rumors.
Why isn't pmcb worth .0626? Come on with all the bullshit I've heard that's supposed to be happening??
"Most" know nobody is buying this pos scam. Looking at L2 there's plenty willing to sell pmcb at .064 today. So where are the buyers?? Like I said MOST know this pos is a scam.
$1 and the odds are way better of winning the powerball than pmcb ever being successful.
Quote:
"How much of the powerball jackpot would you invest into PMCB??"
Thank you, always good to see common sense and the truth when pmcb tries fooling investors yet again.
No
Quote:
"So the improved caps are bringing stunning results?"
I wonder why nobody else cares? 20 years of these claims. It's not been a secret.
SANDHILL Capital Partners LLC came to their senses and sold out their position limiting their losses. Smart.
http://www.nasdaq.com/symbol/pmcb/institutional-holdings
A must read about PMCB management background and previous shadeyness.
Well, I've posted this countless times but here you go:
PMCB's Oh Wise CEO, Kenneth Waggoner, who had previously worked as EVP for ChinaTel, now VelaTel, which is basically a pump & dump Chinese Reverse Merger stock now worth $.0001 cents. Here's a nice summary of some timely dumping:
Quote:"CHTL has certainly treated its stock like an endless money supply. For example, regulatory filings show, CHTL issued more than 30 million shares of stock to consultants and contractors – causing its overhead costs to skyrocket -- during the first nine months of 2009 alone. Since then, those filings show, the company has issued millions of additional shares for similar consulting services.
With the stock blowing past $1 near the end of last year, CHTL insiders began to cash in some of their chips. Isidoro Gutierrez, identified in regulatory filings as CHTL’s chief administrative officer and uncle to two of the company’s top executives, sold at the highest prices – fetching up to $1.55 a share – around the time the stock hit its peak.
In early February, however, a mysterious Mexican trust holding 4.8% of CHTL’s stock (just short of the 5% stake required for detailed disclosures) reported the most lucrative sales of all. Between Dec. 17 and Jan. 22, the trust sold more than 2 million shares of CHTL – at prices ranging up to $1.91 a share – and pocketed almost $3 million in proceeds in the process.
Kenneth Waggoner, CHTL’s outside legal counsel, executed some well-timed sales as well. On the same day thatCHTL announced that Excel had reduced its original funding commitment, for example, Waggoner sold 15,000 shares of stock at just under $1 a share. Two days after CHTL learned that Excel would be unable to make its first big payment – and three days before the company actually disclosed that news – Waggoner followed up with an even bigger sale by cashing in 40,000 shares as the stock headed below 70 cents a share."
Quote:San Diego County Superior Court
Lawsuit filed March 10, 2010-Case no. 37-2010-00087536-CU-EN-CTL
VRT Square LP v. China Tel Group, Mario Alvarez, Kenneth Waggoner, Ken Hobbs, et. al.
Complaint alleges causes of action for, among others, Fraudulent Conveyance, Fraud, Conspiracy Unjust Enrichment and Constructive Trust. Allegations state that a legitimate judgment was obtained by VRT Square against Mario Alvarez and his failed company, Greenleaf Home Loans. Complaint further alleges that after obtaining judgment, Mario Alvarez transferred essentially all his assets and all his stock in China Tel Group Inc. to various friends and family members.
This case can be viewed at the San Diego Superior Court website
From Forbes article:
Quote:"The story line is that Gerova and dozens of satellite companies are secretly being manipulated as part of a bid to pump up share prices and dump them on unsuspecting investors—many of whom are effectively required to own Gerova because of its inclusion in the Russell 2000 and 3000 value indexes. Supposedly behind this complex fraud: graduates of Westmoore Capital. Westmoore is a $53 million Ponzi scheme that the SEC shut down in June."
Westmoore and Gerova have other connections. The now defunct Westmoore acquired a stake in China Tel Group Inc. (OTCBB: CHTL) on July 29, 2008. That same month Gerova entered into an agreement to acquire China Tel. The Gerova-China Tel deal was unwound three months later. China Tel’s chief executive, George Alvarez, served as a Director of Westmoore Holdings, Inc. until September 25, 2009."
Now Waggoner issuing shares to major China Tel Holder Westmoore Capital:
Quote:
SCHEDULE 13D
Under the Securities Exchange Act of 1934
(Amendment No. 0)*
China Tel Group, Inc.
(Name of Issuer)
Series A and Series B Common Stock
(Title of Class of Securities)
Kenneth L. Waggoner, 12526 High Bluff Drive, Suite 155, San Diego, California 92130, (760) 230-8986
(Name, Address and Telephone Number of Person‘s Authorized to Receive Notices and Communications)
Consists of (i) 6,750,000 Series B Shares held by Westmoore Investment L.P., of which Mr. Jennings is general partner; (ii) 2,250,000 Series B Shares held by Westmoore Capital Group Series A, LLC, of which Mr. Jennings is Manager; (iii) 2,036,363 Series B Shares held by Westmoore Management, LLC, of which Mr. Jennings is Chief Executive Officer; (iv) 1,900,000 Series B Shares held by Westmoore Capital Group Series B, LLC, of which Mr. Jennings is Manager; (v) 500,000 Series B Shares held by Westmoore Capital Group Series II, LLC, of which Mr. Jennings is Manager; and (vi) 250,000 Series B Shares held by YYZ Hol
Now Krusty Ken associated with another Ponzi player:
Quote:April 28, 2009|By Joseph Serna
Earlier this month, a Seattle-based firm, Freestone Capital Partners LP and its affiliates, won a judgment against MKA’s Chief Financial Officer Michael Abraham and fund manager Jason Sugarman.
MKA did not pay back the money it owed to Freestone, a judge ruled, and Abraham was ordered to pay back $26.3 million plus interest and Sugarman was ordered to pay back $5.97 million plus interest.
Several people contacted who said they were clients of MKA have reported investing money, and when they failed to see satisfactory, or any return, on their investments, failed to get their money back when they requested it.
The Gateses’ lawsuit alleged the company was operating a make-shift Ponzi scheme to stay afloat, taking on new investors to pay out returns for older ones.
Federal authorities declined to comment on any possible investigation into the company.
Now Waggoner issuing shares to the very same Jason Sugarman:
Quote:Quote:SCHEDULE 13D
Under the Securities Exchange Act of 1934
(Amendment No. 0)*
China Tel Group, Inc.
(Name of Issuer)
Series A and Series B Common Stock
(Title of Class of Securities)
Kenneth L. Waggoner, 12526 High Bluff Drive, Suite 155, San Diego, California 92130, (760) 230-8986
(Name, Address and Telephone Number of Person‘s Authorized to Receive Notices and Communications)
I, Jason Sugarman , a shareholder of China Tel Group, Inc., a Nevada corporation (“Corporation”), do hereby irrevocably appoint George Alvarez, to be my proxy agent, with full power of substitution, and to vote all of my shares of Series B common stock in the Corporation with respect to all matters submitted to the shareholders at all meetings of the shareholders, or any adjournments thereof, and in all consents to any actions taken without a meeting.
Jens Dalsgaard used to be Nuvilex/efoodsaety's PR rep and was a huge stock fraud. I've posted some of his history before. So the connection is definitely there. Gruden, who bought CiAB, was close to Dalsgaard, and Waggoner was hired by Gruden.
Quote:
January 23, 2006 09:45 AM Eastern Standard Time
SCOTTSDALE, Ariz.--(BUSINESS WIRE)--Jan. 23, 2006--Patricia Ross-Gruden, President and CEO of eFoodSafety, Inc. (OTCBB:EFSF), announced today that eFoodSafety, Inc. has been selected by The KonLin Letter as the #1 Stock Pick for 2006. The KonLin Letter reiterates its "Strong Buy" recommendation of EFSF stock.
eFoodSafety, Inc.
by
Redwood Consultants, LLC
Jens Dalsgaard, 415-884-0348
****
(Now for some fun court documentation from around that time:)
On April 13, 2009, in northern California District Court, Location Based Technologies (LBAS.OB), filed suit against Jens Dalsgaard, Redwood Investment LLC, and others, under civil RICO laws. Under the Racketeer Influenced Criminal Organization act, individuals who are members of an enterprise that has committed any two of 35 crimes—27 federal crimes and 8 state crimes—within a 10-year period can be charged with racketeering. RICO also permits a private individual harmed by the actions of such an enterprise to file a civil suit; regardless of whether there is a criminal prosecution, and if successful, the individual can collect treble damages.
A similar suit, alleging fraud and breach of contract, was brought against Dalsgaard in September, 2008 by Sustainable Power Corporation. Again the dispute centered on transfer of unregistered shares to affiliated parties; the case was settled out of court April 24, 2009
Quote:
16 A. I don't know how they acquired 11,360,000
17 shares of Sustainable Power Corp. I do know, okay, how
18 they defrauded Sustainable Power out of 50 to 60 million
19 shares.
20 Q. Well, before we get to that, tell me what
21 Berkshire Capital Management Company is.
22 A. They're investment bankers supposably.
23 Actually, they are cohorts, partners in crime with
24 Redwood Consultants and Jens Dalsgaard.
25 Q. And Berkshire Capital Management is represented
0094
1 by individuals, I would assume?
2 A. Berkshire Cap -- oh, people that work for them?
3 Q. Yes.
4 A. Oh, that's a great assumption, yes, sir.
5 Q. And who is the head of Berkshire Capital Management Company?
6
A. Well, Joe Fiore would be a pretty good guess,
8 and I would probably bet my life on it.
9 Q. All right.
10 A. So I guess I'm pretty sure it's Joe Fiore.
11 Q. How did you come to meet Mr. Fiore?
12 A. I was introduced to him as my investment
13 banker, okay, the person that would make sure that the
14 company had all the money it needed to do all its
15 business and build all its plants and make sure that,
16 you know, everything we did and all our financial needs
17 would be covered by a Mr. Jens Dalsgaard.
18 Q. Dalsgaard introduced you to Fiore, correct?
19 A. I believe that's what I just said, yes, sir.
20 Q. Okay. Other than Mr. Fiore, can you give me
21 the names of some other people associated with Berkshire
22 Capital Management in a management capacity?
22 Q. And I understand that there's some affiliation
23 with Berkshire -- between Berkshire Capital Management
24 and Eat at Joe's, Ltd.?
25 A. Eat at Joe's, Ltd., is -- gee, Eat at Joe
0096
1 Fiore's would be a better title.
2 Q. It's another company that Mr. Fiore owns?
3 A. That is correct.
4 Q. And Diamond Ranch, Ltd., is another one of
5 those entities?
6 A. Can I talk to my attorney for a second?
Quote:
On January 7, 2016, PharmaCyte Biotech, Inc., a Nevada corporation ("Company"), entered into a Stock and Warrant Purchase Agreement with each of Berkshire Capital Management Co., Inc. and SPYR (Joe Fiore), Inc. (collectively, "Investors") and closed a private placement to the Investors of restricted shares of the Company's common stock ("Common Stock") and warrants ("Warrants") to purchase Common Stock ("Private Placement").
Sad isn't it? Pmcb took results from a unregulated, no comparison, back woods study done in BFE from 20 years ago and advertised them to unsuspecting investors as a cure all.
In the process pmcb management has collected millions and investors have lost up to 80%.
Despite all the papers Lohr, Salmons and Gunzberg published in places such as NCIB or Nature trying to sell the idea to colleagues and big pharma there were no takers except for 1. Penny stock attorney extraordinaire Kenn Waggoner who is best known for some shady dealings at former company China-Tel now VelaTel.
Sad.
Buyer Beware!!
PharmaCyte’s platform technology??
What's that cell-in-a-box?
Not theirs. Also trying to rename anything is ng as well.
Won't work sorry.
A wheel is still a wheel no matter what ya call it.
Pmcb confirmed phase 3 trial!
November 5 2013
Nuvilex, Inc. Reaches Unofficial Starting Line of Its Phase 3 Pancreatic Cancer Clinical Trials
NEW YORK, NY--(Marketwired - Nov 5, 2013) - Nuvilex, Inc. (OTCQB: NVLX) made an announcement yesterday that should have investors excited that the company's Phase 3 clinical trials may have unofficially just started. Nuvilex announced that cloning of the cancer-drug-activating cells required for its future Phase 3 clinical trials has begun at Inno Biologics in its cGMP-compliant facilities. Given that the work Inno Biologics is doing can be considered the most important in the process outside of actually enrolling patients in the Phase 3 trials, yesterday's news could be the trial's unofficial starting line.
The company reported yesterday that following receipt by Inno Biologics of four vials of frozen cells capable of converting the well-known anticancer prodrug ifosfamide into its active cancer-killing form, one of the vials was thawed and the cells grown in culture. These are the cells that were previously grown by ViruSure in Vienna, Austria. According to Inno Biologics, the cells were successfully thawed, and approximately 97% of the cells were found to be viable.
Nuvilex explains the cloning process consists of growing cells in multiple microplates to produce a large number of discrete clones. "State-of-the-art" technology is then used in the cloning isolation process. After additional rigorous biochemical testing, those clones determined to be the "best" for Nuvilex's oncological purposes will be selected and additional testing will be done. The company says in the end, the best clones will be propagated to obtain large numbers of cells required for Nuvilex's late-phase clinical trials.
These are truly exciting times for the investors at Nuvilex, Inc. as the company continues on its march towards head to head Phase 3 clinical trials with Eli Lilly and Celgene. To get a better understanding of how the clinical trials will unfold, the trial's sites, SG Austria's role in the trials and much more, listen to our interview with Nuvilex's COO, Dr. Gerry Crabtree: www.stockmarketmediagroup.com/media
CIAB is Batavian Nordics. Pmcb trying to re-patent something they don't own and trying to steal now? Wow! Lawsuits against pmcb will be filed if that's the case.
True
"Provisional patent applications are a way to establish and protect a “date of invention” or “priority filing date” for one year."
It's also a way to string investors along for another year.
Was it granted? Anyone can file a patent for anything. So was it granted? If so where is the agreement that pmcb has an extended license agreement with Bavarian Nordic?
http://appft.uspto.gov/netahtml/PTO/search-bool.html
Bavarian Nordic (Licensor and Owner) and Pharmacyte Licensee) have been unsuccessful to come to an agreement for an extended licensing agreement concerning the protective rights related to the encapsulation of cells. Previous license agreement expired March 27th 2017.
Looks like we may have found the reason it's been 7 months now and no IND.
Can't re-patent same "shit" after it ran its term (20 years). If that were the case hey why not file a patent for the wheel? Not only that but pmcb's own 10k says is gone bye bye.
Are we suggesting pmcb is lying about their bad news??
I posted 2 different links read it for yourself.
Pg26
https://www.sec.gov/Archives/edgar/data/1157075/000168316817001881/pharmacyte_10k-043017.htm
License agreement
https://www.sec.gov/Archives/edgar/data/1157075/000101968714002942/nuvilex_10k-ex1001.htm
Oh? Well they already lost it.
The licensors have rights to terminate the license if the annuity and upkeep fees are not paid to Bavarian Nordic, there is not proper reporting or there is not a clearly documented effort to commercialize this technology. The term of the Bavarian Nordic/GSF License Agreement expired on March 27, 2017, and the parties are currently negotiating an extension.
https://www.sec.gov/Archives/edgar/data/1157075/000168316817001881/pharmacyte_10k-043017.htm
Should be. Pmcb has no legal agreement in place for CIAB. Expired with patents. Wouldn't it be devastating to longs if pmcb actually does gets IND then BAVARIAN NORDIC says thanks but CIAB is ours c-ya!
https://www.sec.gov/Archives/edgar/data/1157075/000101968714002942/nuvilex_10k-ex1001.htm
I'm still waiting for the bid news on pmcb that was suppose to come in June 2013... I can't give anymore info.
Is .066 or .0675 too much to pay for the great pmcb? It seems there are no takers. Hmmm...
The term of the Bavarian Nordic/GSF License Agreement expired on March 27, 2017, and the parties are currently negotiating an extension.
Just like the patents pmcb lost it.
https://www.sec.gov/Archives/edgar/data/1157075/000168316817001881/pharmacyte_10k-043017.htm
BULLSHIT not just part of this post or even 1/2 of it. It's 90% total bullshit written as if it were all proven and factual. Reality is it's of no fact, no verifiable evidence to back any of statements. Just ignorant pmcb propaganda.
To answer your question btw "Sound like a scam?"
YOU BETTCHA BUYER BEWARE.
Quote: "The encapsulation of cells is the next frontier in medicine, especially stem cells.
Any proof or are we going by what pmcb and those financially tied to pmcb say? Believing biased propaganda is quick way to go bankrupt.
We own 14% of the company which owns the best encapsulation technology in the world. It's unique. It's bioinert, retrievable, avoids fibrosis and can be frozen to allow distribution.
pmcb owns 14% of a private 2 man company worth ??? You/We will never know as long as it's private, congratulations on such a worthless investment pmcb. Sounds good to lure the unsuspecting in though doesn't it.
There's nothing else like it.
scam? Sure there are. Companies involved with or testing cell encapsulation? Again there are others as they've been posted here before.
Cell based treatments are the future and big pharmacyte knows this.
Do they? Is there a press release from any big pharma making any even just a fraction of this statement at all factual? Just a little?? Of course not I call Bullshit!
We have a way of directly attacking tumors right beside them and without side effects. Amazing
Says who? PMCB and CIAB creators Lohr, Salomns? Any credible / verifiable evidence to support any of these claims?? Or are we suppose to just believe?? After all it must be true if it was posted here that was written by pmcb and those affiliated! I'm sure those at pmcb are trying to sell me on their sales pitch or SHARES would never lie.... WTF
We have a way of putting insulin creating cells into the body to cure diabetes. Amazing
No shit?? Wow I had no idea pmcb has cured diabetes. Jeez shares at 06 cents and they've cured diabetes!! What a goldmine! (Cough cough) scam!!
We are creating our cell banks for a pivotal clinical trial in pancreatic cancer. Pivotal. Agreed by the FDA.
Who is creating them this week? We've waited over a year to get Austrianova gmp compliant (CGMP unconfirmed by FDA) now suddenly PMCB isn't using Austrianova? FDA didn't agree for "pivotal"! Again ignorant information. What the FDA did say is they would be willing to consider a pivotal one under the right circumstances.
We have an amazing team of world class doctors and oncologists involved and a consortium of the world's best advising the progress of our technology in cancer and diabetes.
Matter of ones personal opinion. If they're so great why did they have to change the trial at the last minute for the FDA? The whole FDA approval process should be a walk in the park for these Dr's if they're what some here believe.
Honestly, does this sound like a scam?
YES
Johnson and Johnson, novo nordisk and many diabetes organizations see cell encapsulation as the biggest hope for a cure for diabetes. The problem has been the immune system attacking those caps.
again any verifiable proof? A document from one of these mentioned? Anything? please!!!
Pharmacyte and ciab have the only solution to that which doesn't involve implants or surgery and all the problems associated with that.
There are others and they're further along
Of course big pharmacyte will want this? The question is how much will they pay and can kw salmon and gunzberg start a bidding war?"
of course? Hmm 20 years and no interested parties even for a low low wholesale cost of $2m! Nope just a crooked otc attorney of failed China-Tel Co scam seen something in CIAB. I wonder what that was....
Some may not like to hear what I have to say as it's mainly negative exposure of shady companies such as pmcb that are opposite of "bulls" illusions. I recommend buying and selling on ones own DD not what others say but I do suggest keeping an open mind and never let emotions cloud ones judgment. Btw nobody has ever lost money heeding my warnings and not buying into the bullshit being spewed by those intending to annihilate unsuspecting investors.
Why .06? Is that all pmcb is worth? Not .07 or .065, ect? I mean if pmcb is as good as some are proclaiming anything short of at least 50 bucks is a steal based on their OS. So confused why anything higher than .06 isn't worth buying?
Investors should be concerned!!
We were a party to the Bavarian Nordic/GSF License Agreement pursuant to which Bavarian Nordic/GSF are the licensors and Bio Blue Bird, our wholly owned subsidiary, is the licensee. The Bavarian Nordic/GSF License Agreement was signed in July 2005 and amended in December 2006 and October 2016. Pursuant to the Bavarian Nordic/GSF License, the licensee is granted an exclusive license to use Bavarian Nordic’s clinical data and know-how encapsulating genetically modified human cells to treat cancer and rights to Bio Blue Bird to the clinical data after expiration of the licensed patent rights. The licensors have rights to terminate the license if the annuity and upkeep fees are not paid to Bavarian Nordic, there is not proper reporting or there is not a clearly documented effort to commercialize this technology. The term of the Bavarian Nordic/GSF License Agreement expired on March 27, 2017, and the parties are currently negotiating an extension.
https://www.sec.gov/Archives/edgar/data/1157075/000168316817001881/pharmacyte_10k-043017.htm
I encourage all who know of illegal activities on pmcb including wash trading to report to the SEC Whistleblower site, link listed below.
Welcome to the Office of the Whistleblower
Assistance and information from a whistleblower who knows of possible securities law violations can be among the most powerful weapons in the law enforcement arsenal of the Securities and Exchange Commission. Through their knowledge of the circumstances and individuals involved, whistleblowers can help the Commission identify possible fraud and other violations much earlier than might otherwise have been possible. That allows the Commission to minimize the harm to investors, better preserve the integrity of the United States' capital markets, and more swiftly hold accountable those responsible for unlawful conduct.
The Commission is authorized by Congress to provide monetary awards to eligible individuals who come forward with high-quality original information that leads to a Commission enforcement action in which over $1,000,000 in sanctions is ordered. The range for awards is between 10% and 30% of the money collected.
https://denebleo.sec.gov/TCRExternal/index.xhtml
Wash trading definition:
A wash trade (not to be confused with a wash sale) is a form of market manipulation in which an investor simultaneously sells and buys the same financial instruments to create misleading, artificial activity in the marketplace.
What was nice about it?
"Nice green close for pmcb"
Should obvious painting of the tape green with a pathetic 488 and a 888 buys be encouraging to investors? Is that the volume we should expect from a company who is claiming curing diabetes and possibly PC? Is that the kinda volume and confidence we should expect for pmcb who few say are partnering with Janssen?
I would think those trades with a value of $32 and $58 dollar buys should have a few more zero's if pmcb is all what rumors suggest.
Thanks for confirming that the email provided information that has not been made public which investors only "suspected". I'll include this in my report. Thank you ;)
Quote:
"I am certain there are posters that would love to discuss the legitimacy of the IR email that 1234jklm shared with us. Why? to avoid discussing the content of the email, which is huge. Like we suspected they are meeting with our funding partner."
Exactly.
"then the funding sources that PharmaCyte has met with and is continuing to meet with can commit."
Yes they sure can use forward looking statements and pmcb relies on them solely as to be able to make uneducated irrational statements.
The problem is this is that the alleged private email contains information not made to the public.
Forward looking statements are generally posted at the bottom of public press reports.
They are of no good to private emails.
I'm really curious about this as it could be pmcb's downfall if in fact it was a legitimate email.
How is it insider info? Really? Looks like we're back to the common sense again. So here goes.
Insider information is a non-public fact regarding the plans or condition of a publicly traded company that could /b]provide a financial advantage when used to buy or sell shares of the company's stock. Insider information is typically gained by someone who is working within or close to a listed company.
Bullshit. I've read it. So either
A. It's made up email
B. It's insider information
I really am hoping it's B.
I love collecting my rewards and seeing crooks like KW go to jail.
Funny how massive dumps going through met with 88 buys to manipulate the pps. All to trick ppl into believing pmcb is something it's not.
Sorry for your loss.
I love how the price is artificially held up by pathetic 488 buys. Number 8 is unlucky number
Wow nice inside info
Helps to read the Legal SEC filings
Pmcb
Employees
As of April 30, 2017, we have four full-time employees and five consultants who function as our Chief Scientific Officer, Director of Diabetes Program Development, Director of Cannabis Program Development, Chairman of the Advisory Board and Senior Strategic Advisor. We use several other consulting scientists, physicians and academics for most of our research and clinical development.
https://www.sec.gov/Archives/edgar/data/1157075/000168316817001881/pharmacyte_10k-043017.htm
I predict crickets is all we will hear on that logical question.
Quote:
"Re: TheBestInvest Post# 73728
I guess a more germane way to ask my question is, if you were about to own the holy Grail of cell encapsulation wouldn't you be buying as many shares as possible?"
Because that's a totally rational question that if answered would reflect negatively on pmcb therefore like the rest of these good questions they get tossed aside for dreamt up illusions that don't make pmcb look like the scam it is.
Quote:
"Why does no one ever talk about no insider buying, or did I miss that conversation?
Does that not concern anyone?"